fosinopril has been researched along with Albuminuria in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 14 (63.64) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Huang, R; Li, X; Melgiri, ND; Qin, X; Sun, Y; Wang, Y | 1 |
| van Toorenenbergen, AW | 1 |
| Asselbergs, FW; Hillege, HL; van der Harst, P; van Gilst, WH; van Veldhuisen, DJ; Voors, AA | 1 |
| Deng, JL; Hou, YB; Li, J; Wang, H; Yue, J | 1 |
| Asselbergs, FW; Brouwers, FP; de Boer, RA; Gansevoort, RT; Hillege, HL; van Gilst, WH; van Veldhuisen, DJ | 1 |
| Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Marasi, G; Mugellini, A; Pasotti, C; Poletti, L; Preti, P; Rinaldi, A; Voglini, C; Zoppi, A | 1 |
| Asselbergs, FW; de Jong, PE; de Zeeuw, D; Diercks, GF; Hillege, HL; Janssen, WM; van Boven, AJ; van Gilst, WH; van Veldhuisen, DJ; Voors, AA | 1 |
| Asselbergs, FW; de Jong, PE; Gans, RO; Hillege, HL; Smit, AJ; van Gilst, WH; van Roon, AM | 1 |
| Asselbergs, FW; Bakker, SJ; de Jong, PE; Geluk, CA; Hillege, HL; van Gilst, WH; Zijlstra, F | 1 |
| Chan, JC; Chan, WB; Chow, CC; Cockram, CS; Ko, GT; Lee, KF; Lo, MK; Ma, RC; Ozaki, R; So, WY; Tong, PC | 1 |
| Asselbergs, FW; Atthobari, J; Boersma, C; de Jong, PE; de Jong-van den Berg, LT; de Vries, R; Gansevoort, RT; Hillege, HL; Postma, MJ; van Gilst, WH | 1 |
| Boomsma, F; de Jong, PE; Gansevoort, RT; Thijs Plokker, HW; van de Wal, RM; van der Harst, P; van Gilst, WH; van Veldhuisen, DJ; Voors, AA | 1 |
| Asselbergs, FW; de Jong, PE; Gans, ROB; Hillege, HL; Smit, AJ; van der Harst, P; van Gilst, WH; van Roon, AM | 1 |
| Gansevoort, RT; Gerritsen, WB; Plokker, TH; van de Wal, RM; van der Harst, P; van der Horst, F; van Gilst, WH; Voors, AA | 1 |
| Basi, S; Fesler, P; Lewis, JB; Mimran, A | 1 |
| Agrati, AM; Alli, C; Cassani, M; Granata, S; Lombardo, M; Zanni, D | 1 |
| García-Robles, R; Rábano, A; Ruilope, LM; Villa, E | 1 |
| Fasching, P; Gasic, S; Jilma, B; Kapiotis, S; Ludwig, C; Veitl, M; Wagner, OF | 2 |
| Carella, MJ; Gossain, VV; Jones, J | 1 |
| Bak, AA; Crijns, HJ; de Jong, PE; Diercks, GF; Janssen, WM; van Boven, AJ; van Gilst, WH | 1 |
3 review(s) available for fosinopril and Albuminuria
| Article | Year |
|---|---|
Comparative Efficacy and Safety of Antihypertensive Agents for Adult Diabetic Patients with Microalbuminuric Kidney Disease: A Network Meta-Analysis.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bayes Theorem; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Follow-Up Studies; Fosinopril; Humans; Hypertension; Indoles; Kidney Diseases; Middle Aged; Patient Safety; Probability; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Young Adult | 2017 |
Prostaglandin E1 for preventing the progression of diabetic kidney disease.
Topics: Albuminuria; Alprostadil; Diabetic Nephropathies; Disease Progression; Drugs, Chinese Herbal; Fosinopril; Humans; Losartan; Proteinuria; Randomized Controlled Trials as Topic; Vasodilator Agents | 2010 |
Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?
Topics: Albuminuria; Antihypertensive Agents; Biomarkers; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Fosinopril; Glomerular Filtration Rate; Humans; Hypertension; Prevalence; Proteinuria | 2008 |
14 trial(s) available for fosinopril and Albuminuria
| Article | Year |
|---|---|
Effect of fosinopril treatment on serum C-reactive protein levels in patients with microalbuminuria.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; C-Reactive Protein; Double-Blind Method; Female; Fosinopril; Humans; Inflammation; Male; Middle Aged; Odds Ratio; Renin-Angiotensin System; Sex Factors | 2008 |
Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria:Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT).
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Cardiovascular Diseases; Female; Follow-Up Studies; Fosinopril; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin | 2011 |
Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients.
Topics: Aged; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Drug Combinations; Female; Fosinopril; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Treatment Outcome | 2002 |
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cohort Studies; Double-Blind Method; Female; Follow-Up Studies; Fosinopril; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Life Tables; Male; Middle Aged; Pravastatin; Treatment Outcome | 2004 |
Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria.
Topics: Albuminuria; Carotid Artery, Common; Double-Blind Method; Female; Fosinopril; Humans; Male; Middle Aged; Pravastatin; Predictive Value of Tests; Stroke; Tunica Intima; Tunica Media | 2005 |
Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial.
Topics: Albuminuria; Antihypertensive Agents; Cardiovascular Diseases; Coronary Disease; Double-Blind Method; Female; Fosinopril; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Middle Aged; Pravastatin; Survival Analysis | 2005 |
The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Fosinopril; Humans; Kidney Failure, Chronic; Male; Middle Aged; Treatment Outcome | 2006 |
Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary albumin excretion in nondiabetic patients.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus; Female; Fosinopril; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis | 2006 |
Long-term effects of pravastatin and fosinopril on peripheral endothelial function in albuminuric subjects.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Brachial Artery; Double-Blind Method; Endothelium, Vascular; Female; Fosinopril; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Longitudinal Studies; Male; Middle Aged; Pravastatin; Vasodilation | 2008 |
Plasma matrix metalloproteinase-9 and ACE-inhibitor-induced improvement of urinary albumin excretion in non-diabetic, microalbuminuric subjects.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus; Female; Fosinopril; Humans; Male; Matrix Metalloproteinase 9; Middle Aged; Placebos | 2007 |
Albuminuria and transferrinuria in essential hypertension. Effects of antihypertensive therapy.
Topics: Adult; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Regression Analysis; Transferrin | 1996 |
Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; E-Selectin; Female; Follow-Up Studies; Fosinopril; Glycated Hemoglobin; Humans; Hypertension; Intercellular Adhesion Molecule-1; Male; Middle Aged; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Prospective Studies; Tissue Plasminogen Activator; Treatment Outcome; Vascular Cell Adhesion Molecule-1 | 1999 |
The effects of a low-dose regimen of fosinopril on elevated urinary albumin excretion in normotensive type 1 diabetic patients.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Administration Schedule; Echocardiography; Female; Fosinopril; Humans; Male; Triglycerides | 1999 |
Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular E
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Kidney Diseases; Male; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Research Design | 2000 |
5 other study(ies) available for fosinopril and Albuminuria
| Article | Year |
|---|---|
Specificity of MMP-9 assays.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antibody Specificity; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Fosinopril; Humans; Matrix Metalloproteinase 9 | 2008 |
[Microalbuminuria--an independent indication for administration of ACE inhibitors: role of fosinopril (PREVEND IT trial)].
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Clinical Trials as Topic; Fosinopril; Humans | 2005 |
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cost-Benefit Analysis; Female; Fosinopril; Health Care Costs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Mass Screening; Middle Aged; Netherlands; Pravastatin; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic | 2006 |
Effects of cicaprost and fosinopril on the progression of rat diabetic nephropathy.
Topics: Albuminuria; Animals; Antihypertensive Agents; Antineoplastic Agents; Blood Glucose; Blood Pressure; Body Weight; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Epoprostenol; Fosinopril; Kidney Glomerulus; Male; Multivariate Analysis; Rats; Rats, Wistar | 1997 |
Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in Type II diabetic patients suffering from microalbuminuria.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Female; Fosinopril; Humans; Male; Middle Aged; Vascular Cell Adhesion Molecule-1 | 1998 |